US Stock MarketDetailed Quotes

GlaxoSmithKline (GSK)

Watchlist
  • 48.650
  • +0.580+1.21%
Close Jan 22 15:59 ET
  • 48.870
  • +0.220+0.45%
Pre 04:24 ET
99.13BMarket Cap13.54P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GlaxoSmithKline (GSK) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
6.68%8.55B
1.29%7.99B
2.08%7.52B
3.46%31.38B
0.81%8.12B
-1.66%8.01B
9.84%7.88B
5.93%7.36B
3.42%30.33B
9.16%8.05B
Operating revenue
6.68%8.55B
1.29%7.99B
2.08%7.52B
3.46%31.38B
0.81%8.12B
-1.66%8.01B
9.84%7.88B
5.93%7.36B
3.42%30.33B
9.16%8.05B
Cost of revenue
-5.80%2.26B
2.03%2.17B
-1.68%1.94B
5.64%9.05B
5.83%2.56B
5.50%2.4B
9.83%2.12B
1.39%1.97B
-10.35%8.57B
8.04%2.42B
Gross profit
12.00%6.29B
1.02%5.82B
3.45%5.58B
2.60%22.33B
-1.35%5.56B
-4.43%5.62B
9.84%5.76B
7.69%5.39B
10.08%21.76B
9.65%5.63B
Operating expense
-31.88%3.7B
-7.73%3.8B
-13.84%3.36B
16.42%16.79B
-25.11%3.34B
38.21%5.43B
32.56%4.12B
33.39%3.9B
10.56%14.42B
50.00%4.46B
Selling and administrative expenses
-41.08%2.24B
-13.18%2.14B
-0.81%2.07B
17.37%11.02B
-0.56%2.66B
65.51%3.8B
8.69%2.47B
-2.61%2.09B
12.10%9.39B
9.84%2.68B
-General and administrative expense
-41.08%2.24B
-13.18%2.14B
-0.81%2.07B
17.37%11.02B
-0.56%2.66B
65.51%3.8B
8.69%2.47B
-2.61%2.09B
12.10%9.39B
9.84%2.68B
Research and development costs
15.76%1.69B
37.03%2.02B
1.95%1.46B
2.86%6.4B
-0.78%2.03B
-7.37%1.46B
10.14%1.48B
13.81%1.43B
13.39%6.22B
13.91%2.05B
Other operating expenses
----
----
-97.94%11M
--9M
---1.18B
-8.72%335M
--318M
--533M
----
----
Operating profit
1,271.96%2.59B
22.90%2.02B
48.72%2.22B
-24.55%5.54B
89.00%2.22B
-90.30%189M
-23.12%1.65B
-28.43%1.49B
9.15%7.35B
-45.79%1.17B
Net non-operating interest income expense
-13.71%-141M
10.67%-134M
19.40%-108M
17.96%-603M
22.31%-195M
21.52%-124M
1.32%-150M
22.99%-134M
11.02%-735M
5.99%-251M
Non-operating interest income
-18.75%26M
108.33%50M
68.75%54M
25.00%60M
26.32%-28M
33.33%32M
-27.27%24M
10.34%32M
54.84%48M
-100.00%-38M
Non-operating interest expense
7.05%167M
5.75%184M
-2.41%162M
-11.72%640M
-7.10%144M
-14.29%156M
-5.95%174M
-18.23%166M
-12.23%725M
-28.57%155M
Total other finance cost
----
----
----
-60.34%23M
----
----
----
----
87.10%58M
----
Other net income (expense)
Special income (charges)
----
----
----
-75.14%-1.23B
-74.89%-1.23B
--0
--0
--0
42.81%-704M
42.73%-705M
-Less：Restructuring and merger&acquisition
----
----
----
121.37%1.75B
----
----
----
----
-50.78%791M
----
-Less:Other special charges
----
----
----
-495.40%-518M
----
----
----
----
76.86%-87M
---86M
Income before tax
3,737.50%2.46B
26.22%1.89B
55.57%2.11B
-42.66%3.48B
48.55%563M
-96.43%64M
-24.76%1.5B
-28.95%1.36B
7.75%6.06B
-76.69%379M
Income tax
31,300.00%312M
26.18%241M
22.63%336M
-30.42%526M
426.32%62M
-100.39%-1M
-21.07%191M
-0.72%274M
6.93%756M
-2,000.00%-19M
Net income
3,198.46%2.14B
26.23%1.65B
63.92%1.77B
-44.40%2.95B
25.88%501M
-95.76%65M
-25.27%1.3B
-33.72%1.08B
-66.02%5.31B
-75.43%398M
Net income continuous Operations
3,198.46%2.14B
26.23%1.65B
63.92%1.77B
-44.40%2.95B
25.88%501M
-95.76%65M
-25.27%1.3B
-33.72%1.08B
7.86%5.31B
-75.51%398M
Net income discontinuous operations
----
----
----
--0
----
----
----
----
--0
----
Minority interest income
6.50%131M
54.96%203M
322.86%148M
-1.05%376M
81.25%87M
75.71%123M
8.26%131M
-75.18%35M
-42.86%380M
-61.60%48M
Net income attributable to the parent company
3,570.69%2.01B
23.02%1.44B
55.26%1.62B
-47.75%2.58B
18.29%414M
-103.96%-58M
-27.77%1.17B
-29.80%1.05B
-67.05%4.93B
-76.59%350M
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
3,570.69%2.01B
23.02%1.44B
55.26%1.62B
-47.75%2.58B
18.29%414M
-103.96%-58M
-27.77%1.17B
-29.80%1.05B
-67.05%4.93B
-76.59%350M
Basic earnings per share
3,664.29%0.998
23.26%0.71
54.47%0.794
-48.03%1.264
17.44%0.202
-103.88%-0.028
-28.18%0.576
-30.16%0.514
-67.26%2.432
-76.82%0.172
Diluted earnings per share
3,607.14%0.982
23.16%0.702
54.72%0.786
-48.12%1.244
17.65%0.2
-103.93%-0.028
-28.21%0.57
-30.41%0.508
-67.26%2.398
-76.71%0.17
Dividend per share
6.43%0.3184
6.97%0.323
1.16%0.3235
8.15%1.217
5.45%0.296
10.70%0.2992
3.82%0.3019
12.82%0.3198
-25.33%1.1253
0.16%0.2807
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 6.68%8.55B1.29%7.99B2.08%7.52B3.46%31.38B0.81%8.12B-1.66%8.01B9.84%7.88B5.93%7.36B3.42%30.33B9.16%8.05B
Operating revenue 6.68%8.55B1.29%7.99B2.08%7.52B3.46%31.38B0.81%8.12B-1.66%8.01B9.84%7.88B5.93%7.36B3.42%30.33B9.16%8.05B
Cost of revenue -5.80%2.26B2.03%2.17B-1.68%1.94B5.64%9.05B5.83%2.56B5.50%2.4B9.83%2.12B1.39%1.97B-10.35%8.57B8.04%2.42B
Gross profit 12.00%6.29B1.02%5.82B3.45%5.58B2.60%22.33B-1.35%5.56B-4.43%5.62B9.84%5.76B7.69%5.39B10.08%21.76B9.65%5.63B
Operating expense -31.88%3.7B-7.73%3.8B-13.84%3.36B16.42%16.79B-25.11%3.34B38.21%5.43B32.56%4.12B33.39%3.9B10.56%14.42B50.00%4.46B
Selling and administrative expenses -41.08%2.24B-13.18%2.14B-0.81%2.07B17.37%11.02B-0.56%2.66B65.51%3.8B8.69%2.47B-2.61%2.09B12.10%9.39B9.84%2.68B
-General and administrative expense -41.08%2.24B-13.18%2.14B-0.81%2.07B17.37%11.02B-0.56%2.66B65.51%3.8B8.69%2.47B-2.61%2.09B12.10%9.39B9.84%2.68B
Research and development costs 15.76%1.69B37.03%2.02B1.95%1.46B2.86%6.4B-0.78%2.03B-7.37%1.46B10.14%1.48B13.81%1.43B13.39%6.22B13.91%2.05B
Other operating expenses ---------97.94%11M--9M---1.18B-8.72%335M--318M--533M--------
Operating profit 1,271.96%2.59B22.90%2.02B48.72%2.22B-24.55%5.54B89.00%2.22B-90.30%189M-23.12%1.65B-28.43%1.49B9.15%7.35B-45.79%1.17B
Net non-operating interest income expense -13.71%-141M10.67%-134M19.40%-108M17.96%-603M22.31%-195M21.52%-124M1.32%-150M22.99%-134M11.02%-735M5.99%-251M
Non-operating interest income -18.75%26M108.33%50M68.75%54M25.00%60M26.32%-28M33.33%32M-27.27%24M10.34%32M54.84%48M-100.00%-38M
Non-operating interest expense 7.05%167M5.75%184M-2.41%162M-11.72%640M-7.10%144M-14.29%156M-5.95%174M-18.23%166M-12.23%725M-28.57%155M
Total other finance cost -------------60.34%23M----------------87.10%58M----
Other net income (expense)
Special income (charges) -------------75.14%-1.23B-74.89%-1.23B--0--0--042.81%-704M42.73%-705M
-Less：Restructuring and merger&acquisition ------------121.37%1.75B-----------------50.78%791M----
-Less:Other special charges -------------495.40%-518M----------------76.86%-87M---86M
Income before tax 3,737.50%2.46B26.22%1.89B55.57%2.11B-42.66%3.48B48.55%563M-96.43%64M-24.76%1.5B-28.95%1.36B7.75%6.06B-76.69%379M
Income tax 31,300.00%312M26.18%241M22.63%336M-30.42%526M426.32%62M-100.39%-1M-21.07%191M-0.72%274M6.93%756M-2,000.00%-19M
Net income 3,198.46%2.14B26.23%1.65B63.92%1.77B-44.40%2.95B25.88%501M-95.76%65M-25.27%1.3B-33.72%1.08B-66.02%5.31B-75.43%398M
Net income continuous Operations 3,198.46%2.14B26.23%1.65B63.92%1.77B-44.40%2.95B25.88%501M-95.76%65M-25.27%1.3B-33.72%1.08B7.86%5.31B-75.51%398M
Net income discontinuous operations --------------0------------------0----
Minority interest income 6.50%131M54.96%203M322.86%148M-1.05%376M81.25%87M75.71%123M8.26%131M-75.18%35M-42.86%380M-61.60%48M
Net income attributable to the parent company 3,570.69%2.01B23.02%1.44B55.26%1.62B-47.75%2.58B18.29%414M-103.96%-58M-27.77%1.17B-29.80%1.05B-67.05%4.93B-76.59%350M
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders 3,570.69%2.01B23.02%1.44B55.26%1.62B-47.75%2.58B18.29%414M-103.96%-58M-27.77%1.17B-29.80%1.05B-67.05%4.93B-76.59%350M
Basic earnings per share 3,664.29%0.99823.26%0.7154.47%0.794-48.03%1.26417.44%0.202-103.88%-0.028-28.18%0.576-30.16%0.514-67.26%2.432-76.82%0.172
Diluted earnings per share 3,607.14%0.98223.16%0.70254.72%0.786-48.12%1.24417.65%0.2-103.93%-0.028-28.21%0.57-30.41%0.508-67.26%2.398-76.71%0.17
Dividend per share 6.43%0.31846.97%0.3231.16%0.32358.15%1.2175.45%0.29610.70%0.29923.82%0.301912.82%0.3198-25.33%1.12530.16%0.2807
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -